MAPT and Alzheimer disease: Analysis of these DEGs and the comparisons from which they have been found leads us to conclude that decreased levels of neurosteorids play an important role as a risk factor for AD considering that low levels are associated with an increase in Aβ and hyperphosphorylated tau.